U.S. Bone Glue Market is expected to grow with a CAGR of 6.7% | Global Industry Analysis by Cryolife, Luna Innovations Incorporated, Johnson and Johnson, Cohera Medical Inc., Tissuemed and C.R. Bard Inc.

According to Optima Insights, the U.S.Bone GlueMarket is estimated to be valued at US$ XX million in 2017 and is projected to exhibit a CAGR of 6.7% over the forecast period (2019 – 2023).

Key Trends and Analysis of the U.S. Bone GlueMarket:

Bone glue usage is high on bone fractures and hip and knee procedures. Osteoporosis is one of the major causes for bone ruptures/cracks and it prevails high in geriatric population. For instance, the prevalence ratio of osteoporosis increases from 5.4% at 45-50 years to 52.5% at 80-85 years among women. According to National Osteoporosis Foundation, 2002, in U.S. there were around 6-7 million females aged over 50 years were suffering from osteoporosis and 21.8 million suffering from osteopenia a condition that occurs when the body doesn't make new bone as quickly as it reabsorbs old bone. As bone health significantly deteriorates with age, this would lead to a large number of falls and resultant fractures. According to Centers for Disease Control and Prevention, 2016, Over 800,000 patients a year are hospitalized because of a fall injury, most often because of a head injury or hip fracture and more than 95% of hip fractures are caused by falling,8 usually by falling sideways.

Make an Inquiry Here @ https://www.optimainsights.org/categories/orthopedic-spine-trauma-devices

Increased innovative technology for developing advanced in bone glue market to bring success in orthopaedic bone glue market over the forecast period. For instance, an emerging company LaunchPad Medical, LLC, is developing a product which in under trail is aInternational Space Station for experiments in microgravity environment, and the preclinical trial are been conducted. Mr. Brian Hess, CEO of Launch-Pad Medical, explains that this technology or product could replace the need for complicated surgeries of metal plates, screws and rods.

However, stringent regulations in U.S.on institutions and universities who experiment on animals should be U.S. Department of Agriculture and Facilities, licensed and or registered, regulated animals must be inspected yearly by USDA’s Animal and Plant Health Inspection Service. Such regulations had hit the U.S. Bone Glue Market by inhibiting the production of natural glue obtained from animals. The non-animal substitutes i.e. chemical or synthetic glue are relatively more expensive and can also leads complication further, if not treated properly. There are certain draw backs in synthetic glues such as the irritation surrounding the skin caused by the cement, irregular composition of bone cement sometimes leads to breakdown or can form cracks in the cement leading to loosing of treated joints, such breakages of cement are associated with cemented arthroplasty, is one of the major concerns hampering the bone glue market.

Key Market Takeaways:

• The U.S. Bone GlueMarket is expected to exhibit a CAGR of 6.7% during the forecast period (2019 – 2023), due to increasedpreference on natural glues derived from animal and plant sourcethan the chemical substitutes

• Market growth has observed due to the companies adopt the wide product portfolio and product pipeline that can heal the cracked bones, also, the products are available at the low cost

• A fewkey competitors operating in the U.S. Bone Glue Market include Cryolife, Luna Innovations Incorporated, Johnson and Johnson, Cohera Medical Inc., Tissuemed Ltd., Integra Lifesciences Corporation, Baxter International Inc., B.BraunMelsungen AG, DENTSPLY SIRONA Inc., Chemence Medical Inc. and C.R. Bard Inc.

Optima Insights has a geographical/regional coverage on five major regions, include, North America, Latin America, Europe, Asia Pacific,and Middle East & Africa. This extensive regional coverage also deep dives into major 26 countries, include, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.

For more details please log on to: www.optimainsights.org

About Optima Insights:

Optima Insights is an innovative research and insights driven enterprise committed to offer actionable intelligence to the global life science and healthcare market players. We believe that meaningful insights and improved strategic content holds the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas to develop targeted research solutions at compelling price point. We continuously support clients through the entire journey map to enable them take better business decisions towards attaining market leadership.

Contact Details:
Chucks G
Director - Global Sales & BD
Optima Insights Pvt. Ltd.,
mail: sales@optimainsights.org
mob: +1 4242554365
www.optimainsights.org

This release was published on openPR.